Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,5832.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,4235.0,1.0,=,1.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1816.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,526.0,1.0,=,3.5
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1087.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,356.0,1.0,=,3.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,874.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,405.0,1.0,=,2.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,843.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,300.0,1.0,=,2.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,650.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,219.0,1.0,=,3.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,5658.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,3653.0,1.0,=,1.5
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,4310.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,3619.0,1.0,=,1.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,3383.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,283.0,1.0,=,12.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2292.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,712.0,1.0,=,3.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2247.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,1223.0,1.0,=,1.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2071.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,962.0,1.0,=,2.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1973.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,1237.0,1.0,=,1.6
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1865.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,785.0,1.0,=,2.4